<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gluconeogenesis (GNG) is enhanced in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>In experimental animals, insulin at high doses decreases the incorporation of labeled GNG precursors into plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Whether physiological <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> has any effect on total GNG in humans has not been determined </plain></SENT>
<SENT sid="3" pm="."><plain>We combined the insulin clamp with the (2)<z:chebi fb="0" ids="15377">H(2)O</z:chebi> technique to measure total GNG in 33 subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (BMI 29.0 +/- 0.6 kg/m(2), fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> 8.1 +/- 0.3 mmol/l) and in 9 nondiabetic BMI-matched subjects after 16 h of fasting and after euglycemic <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>A primed-constant infusion of 6,6-(2)H-<z:chebi fb="105" ids="17234">glucose</z:chebi> was used to monitor endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> output (EGO); insulin (40 mU </plain></SENT>
<SENT sid="5" pm="."><plain>min(-1) </plain></SENT>
<SENT sid="6" pm="."><plain>m(-2)) was then infused while clamping plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> for 2 h (at 5.8 +/- 0.1 and 4.9 +/- 0.2 mmol/l for diabetic and control subjects, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>In the fasting state, EGO averaged 15.2 +/- 0.4 micromol </plain></SENT>
<SENT sid="8" pm="."><plain>min(-1) </plain></SENT>
<SENT sid="9" pm="."><plain>kg(-1)(ffm) (62% from GNG) in diabetic subjects and 12.2 +/- 0.7 micromol </plain></SENT>
<SENT sid="10" pm="."><plain>min(-1) </plain></SENT>
<SENT sid="11" pm="."><plain>kg(-1)(ffm) (55% from GNG) in control subjects (P &lt; 0.05 or less for both fluxes) </plain></SENT>
<SENT sid="12" pm="."><plain>Glycogenolysis (EGO - GNG) was similar in the two groups (P = NS) </plain></SENT>
<SENT sid="13" pm="."><plain>During the last 40 min of the clamp, both EGO and GNG were significantly (P &lt; 0.01 or less, compared with fasting) inhibited (EGO 7.1 +/- 0.9 and 3.6 +/- 0.5 and GNG 7.9 +/- 0.5 and 4.5 +/- 1.0 respectively) but remained significantly (P &lt; 0.05) higher in diabetic subjects, whereas glycogenolysis was suppressed completely and equally in both groups </plain></SENT>
<SENT sid="14" pm="."><plain>During <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, GNG micromol </plain></SENT>
<SENT sid="15" pm="."><plain>min(-1) </plain></SENT>
<SENT sid="16" pm="."><plain>kg(-1)(ffm) in diabetic and control subjects, was reciprocally related to plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> clearance </plain></SENT>
<SENT sid="17" pm="."><plain>In conclusion, physiological <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> suppresses GNG by approximately 20%, while completely blocking glycogenolysis </plain></SENT>
<SENT sid="18" pm="."><plain>Resistance of GNG (to insulin suppression) and resistance of <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (to insulin stimulation) are coupled phenomena </plain></SENT>
<SENT sid="19" pm="."><plain>In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the excess GNG of the fasting state is carried over to the insulinized state, thereby contributing to <z:chebi fb="105" ids="17234">glucose</z:chebi> overproduction under both conditions </plain></SENT>
</text></document>